Skip to Content
Print Save

Oxiavarry (niacinamide / tretinoin topical) Disease Interactions

There are 2 disease interactions with Oxiavarry (niacinamide / tretinoin topical):

Major

Retinoid/retinoid-like topical (Includes Oxiavarry) eczema

Major Potential Hazard, High plausibility. Applies to: Eczema

Topical retinoids may cause severe irritation on eczematous skin. Therapy with topical retinoids should be avoided on abraded or eczematous skin.

References

  1. "Product Information. Differin (adapalene topical)." Galderma Laboratories Inc, Fort Worth, TX.
  2. "Product Information. Tazorac (tazarotene topical)." Allergan Inc, Irvine, CA.
  3. "Product Information. Retin-A (tretinoin)." Ortho Pharmaceutical Corporation, Raritan, NJ.
Moderate

Retinoid/retinoid-like topical (Includes Oxiavarry) sunburn

Moderate Potential Hazard, High plausibility. Applies to: Sunburn

Retinoid-like products can cause extreme irritation when applied to sunburned skin. Patients with sunburn should be cautioned not to use retinoid-like acne products until fully recovered, and to avoid prolonged exposure to sunlight (including sunlamps) and use sunscreen/protective clothing during treatment with these products.

References

  1. "Product Information. Differin (adapalene topical)." Galderma Laboratories Inc, Fort Worth, TX.
  2. Rosenbluth M "Adverse reaction to retin-A." J Am Dent Assoc 119 (1989): 346
  3. "Product Information. Retin-A (tretinoin)." Ortho Pharmaceutical Corporation, Raritan, NJ.
  4. "Product Information. Tazorac (tazarotene topical)." Allergan Inc, Irvine, CA.
View all 4 references

Oxiavarry (niacinamide / tretinoin topical) drug interactions

There are 11 drug interactions with Oxiavarry (niacinamide / tretinoin topical)

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer